Evidence map›Paper›PMID 35893012›Full record

ArticleEpigenomes2022

Global m6A RNA Methylation in SARS-CoV-2 Positive Nasopharyngeal Samples in a Mexican Population: A First Approximation Study.

Jorge Luis Batista-Roche, Bruno Gómez-Gil, Gertrud Lund, César Alejandro Berlanga-Robles, Alejandra García-Gasca

Open access · diamondAbstract read
In one paragraph

Article in Epigenomes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Targeting G9a-miScience · 2025
    Article
  2. NCellular & molecular biology letters · 2023
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jorge Luis Batista-RocheMolecular and Cellular Biology, Centro de Investigación en Alimentación y Desarrollo, Mazatlán 82112, Mexico.ORCID 0000-0003-4649-1354
Bruno Gómez-GilMicrobial Genomics, Centro de Investigación en Alimentación y Desarrollo, Mazatlán 82112, Mexico.ORCID 0000-0002-3695-3597
Gertrud LundDepartment of Genetic Engineering, CINVESTAV Irapuato Unit, Irapuato 36821, Mexico.ORCID 0000-0003-3556-8520
César Alejandro Berlanga-RoblesEnvironmental Management, Centro de Investigación en Alimentación y Desarrollo, Mazatlán 82112, Mexico.ORCID 0000-0002-3860-3523
Alejandra García-GascaMolecular and Cellular Biology, Centro de Investigación en Alimentación y Desarrollo, Mazatlán 82112, Mexico.ORCID 0000-0002-4496-2434
Centro de Investigación en Alimentación y Desarrollo · MXInstituto Tecnológico Superior de Irapuato · MX

Funding

Consejo Nacional de Ciencia y Tecnología PP-F003LDM-COVID 2017710752
6 · The paper itself

Abstract

The Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) is the causal agent of COVID-19 (Coronavirus Disease-19). Both mutation and/or recombination events in the SARS-CoV-2 genome have resulted in variants that differ in transmissibility and severity. Furthermore, RNA methylation of the N6 position of adenosine (m6A) is known to be altered in cells infected with SARS-CoV-2. However, it is not known whether this epitranscriptomic modification differs across individuals dependent on the presence of infection with distinct SARS-CoV-2 variants, the viral load, or the vaccination status. To address this issue, we selected RNAs (

Indexed as

m6A methylationnasopharyngeal samplesSARS-CoV-2viral variants

Identifiers

PMID35893012
PMCPMC9326742
OpenAlexW4283700002

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.